• GE HealthCare reported first-quarter 2026 net income attributable to GE HealthCare of $389 million, down 31%.
• Revenue rose 7.4% to $5.13 billion.
• Adjusted EBIT slipped 3.4% to $691 million.
• Cash flow from operating activities increased to $290 million; acquisition of Intelerad closed for a purchase price of $2.3 billion.
• Full-year 2026 outlook kept organic revenue growth at 3%-4%, while adjusted EPS guidance was cut to $4.80-$5 from $4.95-$5.15.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GE HealthCare Technologies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260429090715) on April 29, 2026, and is solely responsible for the information contained therein.